Timing, Expertise, and Innovation: Navigating the Path to Preclinical Success

Medicon Valley Alliance and GemPharmatech would like to welcome you to a Good Morning Meeting 24th of September 2024.

In the fast-paced world of drug development, timing is everything, and the expertise of your research partner can make or break your project. Join us for an exclusive event designed to help you master the art of selecting the right preclinical partner, ensuring your research advances seamlessly from concept to clinical success.

What you will gain:

• Strategic Insights: Get a clear understanding of the key factors that influence the success of your preclinical research and how to manage them effectively
• Real-World Applications: Hear from industry leaders who have successfully collaborated with GemPharmatech to overcome challenges and achieve their research goals
• Actionable Advice: Learn practical tips on optimizing your project’s timeline and maximizing the impact of your preclinical studies

Why choose GemPharmatech?

• Unparalleled Resources:
  With over 25,000 mouse strains and models, we offer one of the most extensive resources available, providing you with the exact tools needed for groundbreaking research
• Comprehensive Therapeutic Expertise:
  Our expertise spans across major therapeutic areas including Oncology and Immunology, Metabolic Diseases, Neurodegenerative Diseases, Autoimmune Diseases, Rare Diseases, and Gut Microbiota Whatever your focus, we have the specialized knowledge to support your research
• Cost-Efficient Solutions:
  Innovation doesn’t have to be expensive. Our offerings are designed to reduce your research costs while maintaining the highest standards of quality and precision
• Accelerated Timelines:
  In the race to bring new therapies to market, speed is crucial. Our efficient processes ensure a fast timeline, helping you meet critical deadlines and advance to the next stage with confidence

Special benefits for attendees:

• Exclusive Discount:
  As a token of appreciation, all participants will receive a 15% OFF discount on their first deal with GemPharmatech

Date: Monday 23rd of September, 2024
Time: 10:30 – 13:30
Venue: Medicon Village, Auditorium, Building Inspira, Scheelevägen 4, Lund, Sweden

SIGN UP

Program

Speakers​

	Tao Wang, PhD, Vice President of GemPharmatech CO. Ltd. & CEO of GemPharmatech subsidiary (Guangdong, China) Dr. Tao Wang holds a Ph.D. in Biomedical Engineering from the University of Western Australia and possesses a multidisciplinary background in the science, engineering, and biomedical fields. He has served as a scientist at various overseas research institutions and publicly traded companies, where he achieved significant research advancements. Upon returning to China, he assumed the role of General Manager of the Guangdong subsidiary of GemPharmatech Co., Ltd., where he was responsible for the company’s establishment, research and development, production, and operational management. Subsequently, he took on the position of Vice President of Marketing, where he successfully built a high-performing marketing team and established an overseas team. His leadership was crucial in the company achieving a successful public listing during his tenure.
	Hongyan Sun, PhD, Senior scientist at GemPharmatech Dr. Sun earned her PhD from the Institute of Zoology at the Chinese Academy of Sciences and boasts over a decade of expertise in oncology pharmacology and efficacy operations. Throughout her career, she has led teams in pioneering and validating numerous inovative mouse models and has established a premier service platform for anti-tumor pharmacology and efficacy. Her extensive hands-on experience spans a range of innovative therapies, including immune checkpoint inhibitors, cell and gene therapies and cancer vaccines.
	Elaine Rong, Business Development Manager at GemPharmatech Elaine is the Business Development Manager responsible for overseeing the Nordic market in GemPharmatech. She is open to discussing any collaboration opportunities, particularly in providing a wide range of mouse models, preclinical studies, and other laboratory animals. Elaine is also focused on identifying and establishing connections with potential distributors in the region.

​

Organized by	In collaboration with